EPAS1 and renal cell carcinoma: Specific direct interaction of HIF2α (but not HIF1α or HIF3α) with eIF3e led to HIF2α degradation via the proteasome pathway in a hypoxia- and VHL-independent manner in renal cell carcinoma 786-O cells.